Final workshop of the SafetyFIRST study in Bonn Final workshop of the SafetyFIRST study in Bonn

On 20 March 2026, the final workshop of the nationwide SafetyFIRST study – funded by the Federal Ministry of Health (BMG) and conducted by the Universities of Erlangen and Bonn – took place at the Federal Institute for Drugs and Medical Devices (BfArM) in Bonn. Our department played a key role in the study as a centre of expertise. Over 50 participants engaged in lively discussions about the sometimes surprising results and the implementation of interprofessional intervention strategies to improve medication safety for patients undergoing oral anticancer therapy. We would like to extend our sincere thanks to everyone involved for their commitment!